REGN - Spark Newswire

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Tuesday, Oct. 5, 2021: PRLB, SKLZ, BYDDY, SE, PYPL, SMFR, CLLS, SDGR, VRTX, REGN, OPEN, SI

Today, 9:01 PM

Proto Labs (PRLB) - 44,700 Shares Skillz (SKLZ) - 952,252 BYD (BYDDY) - 26,237 Sea (SE) - 16,517 PayPal (PYPL) - 43,209 Sema4 (SMFR) - 2,453 Cellectis (CLLS) - 23,802 Schrodinger (SDGR) - 8,800 Vertex

BYDDY

5 minute read

Tesla and Merck Give Investors Some Hope

By JJ Kinahan

Today, 9:01 PM

Friday’s rally appears to have lost its momentum over the weekend because stock futures are trading lower before Monday’s open. China’s troubled real estate developer Evergrande continues to be a drag on stocks. Hong Kong’s Hang Seng Index (HIS:HK) dropped 2% as trading on Evergrande was halted.

GILD

7 minute read

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates

By Shanthi Rexaline

Today, 9:01 PM

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned.

ANIP

2 minute read

Why Moderna, Novavax And Other COVID-19 Vaccine Stocks Are Plummeting

By Shanthi Rexaline

Today, 9:01 PM

The COVID-19 pandemic proved to be a boon for many biopharma companies that benefited from their foray into the development of vaccines and/or treatments against the novel coronavirus. Shares of most of them reached incredibly high valuations even after discounting for the COVID opportunity.

AZN

1 minute read

Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail

By Vandana Singh

Today, 9:01 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Roche Holdings AG (OTC:RHHBY) announced positive data from Phase 2/3 2066 study of Ronapreve (casirivimab and imdevimab) or…

REGN

2 minute read

New England Journal of Medicine Publishes Phase 3 Trial Results for REGEN-COV™ (casirivimab and imdevimab) to Treat COVID-19

By Michael Horton

Today, 9:01 PM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the New England Journal of Medicine (NEJM) published positive detailed results from a Phase 3 trial that assessed the

REGN

1 minute read

Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial

By Vandana Singh

Today, 9:01 PM

Graybug Vision Inc (NASDAQ: GRAY) has provided a full-data analysis from the 18-month Phase 2b ALTISSIMO trial of GB-102 for wet age-related macular degeneration (wet AMD).

GRAY

5 minute read

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer’s Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive

By Shanthi Rexaline

Today, 9:01 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27)

AFIB

1 minute read

Glaxo – Vir Biotech’s COVID Treatment Approved In Japan

By Vandana Singh

Today, 9:01 PM

Japan's health ministry expert committee has approved GlaxoSmithKline Plc (NYSE: GSK) - Vir Biotechnology Inc's (NASDAQ: VIR) sotrovimab, a COVID-19 antibody therapy.

GSK

1 minute read

WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access

By Vandana Singh

Today, 9:01 PM

The World Health Organization (WHO) has supported another COVID-19 therapeutic but urged the related companies and governments to address the…

REGN

Feed Symbols: REGN